NZ502405A - Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin - Google Patents
Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skinInfo
- Publication number
- NZ502405A NZ502405A NZ502405A NZ50240598A NZ502405A NZ 502405 A NZ502405 A NZ 502405A NZ 502405 A NZ502405 A NZ 502405A NZ 50240598 A NZ50240598 A NZ 50240598A NZ 502405 A NZ502405 A NZ 502405A
- Authority
- NZ
- New Zealand
- Prior art keywords
- skin
- therapy system
- transdermal therapy
- active agent
- tts
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 4
- 238000002560 therapeutic procedure Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 239000010410 layer Substances 0.000 abstract 6
- 230000004888 barrier function Effects 0.000 abstract 3
- 239000011159 matrix material Substances 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000000853 adhesive Substances 0.000 abstract 1
- 239000011241 protective layer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A transdermal therapy system (TTS) for delivering active ingredient through the skin to a human or an animal body, comprising a matrix which contains the active ingredient, and which has a self-adhesive active layer which faces towards the skin and which can be covered with a detachable protective layer before application, and a cover layer. The cover layer is impenetrable to the active agent and forms a barrier between the matrix and the outside. The system is characterised in that at the time of application, a part-section of the surface of the active layer of the matrix which releases the active agent and faces towards the skin is covered by a barrier layer (3), this barrier layer being impenetrable to the active agent.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19733981A DE19733981A1 (en) | 1997-08-06 | 1997-08-06 | Transdermal therapeutic system (TTS) for the delivery of active ingredient through the skin to an organism and method for application to the skin |
| PCT/EP1998/004824 WO1999007349A2 (en) | 1997-08-06 | 1998-08-01 | Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ502405A true NZ502405A (en) | 2001-01-26 |
Family
ID=7838128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ502405A NZ502405A (en) | 1997-08-06 | 1998-08-01 | Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0986374A2 (en) |
| JP (1) | JP2002517379A (en) |
| KR (1) | KR20010022629A (en) |
| AU (1) | AU737115B2 (en) |
| CA (1) | CA2298442A1 (en) |
| DE (1) | DE19733981A1 (en) |
| HU (1) | HUP0003347A3 (en) |
| ID (1) | ID24195A (en) |
| IL (1) | IL134007A0 (en) |
| NO (1) | NO20000376D0 (en) |
| NZ (1) | NZ502405A (en) |
| PL (1) | PL338793A1 (en) |
| SK (1) | SK1482000A3 (en) |
| TR (1) | TR200000249T2 (en) |
| WO (1) | WO1999007349A2 (en) |
| ZA (1) | ZA987006B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10027258C1 (en) * | 2000-05-31 | 2001-10-31 | Lohmann Therapie Syst Lts | Transdermal therapeutic system, for local/systemic delivery of non-steroidal antiinflammatory agents, comprises a permeable, elastic water and air permeable backing layer and an impermeable two-phase drug-containing matrix layer |
| DE10056014A1 (en) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Laminated plaster with active substance, used as transdermal therapeutic system, has impermeable barrier layer on side away from skin and separable carrier layer with adhesive on side towards skin |
| CN1589128A (en) | 2001-11-23 | 2005-03-02 | 科洛普拉斯特公司 | Wound dressing |
| DE102004020463A1 (en) * | 2004-04-26 | 2005-11-10 | Grünenthal GmbH | Drug delivery system consisting of a drug-containing patch and at least one Wirkstoffabgaberegulierungsmittel |
| DE202005014347U1 (en) * | 2005-09-09 | 2007-01-18 | Grünenthal GmbH | Application system for a medicated plaster and Wirkstoffgabgaberegulierungsmittel |
| HU0900117D0 (en) | 2009-02-26 | 2009-04-28 | Genetic Immunity Kutatasi | Topical or transdermal delivery kit |
| DE102017125281A1 (en) | 2017-10-27 | 2019-05-02 | Dermatools Biotech Gmbh | Device for providing a skin or wound dressing |
| DE102018216244A1 (en) | 2018-09-24 | 2020-03-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system with barrier layer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340190C (en) * | 1988-08-01 | 1998-12-15 | The Kendall Company | Discontinuous adhesive surface |
| DE3908431A1 (en) * | 1989-03-15 | 1990-09-27 | Lohmann Therapie Syst Lts | TRANSDERMAL SYSTEM WITH STAGE SUBSTANCE DELIVERY AND USE FOR LOCAL OR SYSTEMIC DISPENSER |
| EP0593807A1 (en) * | 1992-10-22 | 1994-04-27 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation |
| DE19503336C2 (en) * | 1995-02-02 | 1998-07-30 | Lohmann Therapie Syst Lts | Pharmaceutical form for delivering active substances to wounds, process for their preparation and their use |
| WO1997006784A1 (en) * | 1995-08-15 | 1997-02-27 | Universite Libre De Bruxelles | Liposomes preparation method and plant |
| US5840327A (en) * | 1995-08-21 | 1998-11-24 | Alza Corporation | Transdermal drug delivery device having enhanced adhesion |
-
1997
- 1997-08-06 DE DE19733981A patent/DE19733981A1/en not_active Withdrawn
-
1998
- 1998-08-01 ID IDW20000165A patent/ID24195A/en unknown
- 1998-08-01 CA CA002298442A patent/CA2298442A1/en not_active Abandoned
- 1998-08-01 EP EP98947418A patent/EP0986374A2/en not_active Withdrawn
- 1998-08-01 AU AU94344/98A patent/AU737115B2/en not_active Ceased
- 1998-08-01 PL PL98338793A patent/PL338793A1/en unknown
- 1998-08-01 SK SK148-2000A patent/SK1482000A3/en unknown
- 1998-08-01 JP JP2000506942A patent/JP2002517379A/en active Pending
- 1998-08-01 HU HU0003347A patent/HUP0003347A3/en unknown
- 1998-08-01 TR TR2000/00249T patent/TR200000249T2/en unknown
- 1998-08-01 WO PCT/EP1998/004824 patent/WO1999007349A2/en not_active Ceased
- 1998-08-01 IL IL13400798A patent/IL134007A0/en unknown
- 1998-08-01 KR KR1020007001223A patent/KR20010022629A/en not_active Withdrawn
- 1998-08-01 NZ NZ502405A patent/NZ502405A/en unknown
- 1998-08-05 ZA ZA987006A patent/ZA987006B/en unknown
-
2000
- 2000-01-25 NO NO20000376A patent/NO20000376D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999007349A3 (en) | 1999-08-05 |
| AU9434498A (en) | 1999-03-01 |
| CA2298442A1 (en) | 1999-02-18 |
| NO20000376L (en) | 2000-01-25 |
| TR200000249T2 (en) | 2000-08-21 |
| IL134007A0 (en) | 2001-04-30 |
| AU737115B2 (en) | 2001-08-09 |
| JP2002517379A (en) | 2002-06-18 |
| WO1999007349A2 (en) | 1999-02-18 |
| ZA987006B (en) | 1999-02-08 |
| PL338793A1 (en) | 2000-11-20 |
| SK1482000A3 (en) | 2000-07-11 |
| NO20000376D0 (en) | 2000-01-25 |
| KR20010022629A (en) | 2001-03-26 |
| ID24195A (en) | 2000-07-13 |
| EP0986374A2 (en) | 2000-03-22 |
| HUP0003347A2 (en) | 2001-02-28 |
| DE19733981A1 (en) | 1999-02-11 |
| HUP0003347A3 (en) | 2001-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW349024B (en) | Freeze-dried liposome delivery system for application of skin treatment agents | |
| WO1991008795A3 (en) | Improved iontophoretic delivery method | |
| WO1997004818A3 (en) | Transdermal therapeutic sysgtem for administering active agents to the human body via the skin | |
| PT100323A (en) | DEVICE FOR THE REDUCTION OF SENSATIONS DURING THE IONTOFORETIC ADMINISTRATION OF A THERAPEUTIC AGENT | |
| PL335446A1 (en) | Transcutaneous therapeutic system | |
| MXPA05006987A (en) | Active agent delivery device having composite members. | |
| MY103355A (en) | Active substance-containing plaster of the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin | |
| ATE396714T1 (en) | TRANSDERMAL THERAPEUTIC SYSTEM WITH IMPROVED LONG-TERM COMFORT | |
| NZ509215A (en) | Transdermal plaster preparation containing at least one active ingredient which influences blood serum lipid levels | |
| CA2387143A1 (en) | Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin | |
| NZ502405A (en) | Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin | |
| IL92924A0 (en) | Superficial therapeutic system comprising an antineoplastic active substance | |
| WO2002017928A3 (en) | Transdermal therapeutic system for releasing exemestane | |
| ATE206045T1 (en) | TRANSDERMAL THERAPEUTIC SYSTEM WITH HYDROLYTIC PROTECTION | |
| DE59504233D1 (en) | ESTRADIOL TTS WITH WATER-BINDING ADDITIVES | |
| HK1026846A (en) | Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin | |
| ES2136605T3 (en) | ELECTRICAL DEVICE FOR THE TRANSDERMIC APPLICATION OF PHARMACS WITH A COUNTERRESPECT AGENT. | |
| HUT43959A (en) | Medical plasters containing non-continous adhesive layer suitable for getting in therapeutic active agents into skin or through the skin into organism | |
| CA2060994A1 (en) | Electrical transdermal drug applicator with counteractor and method of drug delivery | |
| SG49645A1 (en) | A method of treating liver disease and like indications with vasodilating agents | |
| PL325557A1 (en) | Agent for use in prophylactics and/or treatmet of human and animal hair loss | |
| UA28769A (en) | Method of treatment of the skin radiation damages | |
| UA37509A (en) | Method for treating fetoplacental insufficiency | |
| BR9804054A (en) | Antiprogestin deposit therapy method. |